The Future of Radiopharmaceuticals in the Treatment of Prostate Cancer – Philip Kantoff
News & media
Radioligands Advance Radiotherapy Premise With Greater Precision
Philip Kantoff: Next Generation Radiopharmaceutical Drug Development
Convergent Therapeutics — Next Generation Radiopharmaceutical Therapies for Cancer
Interview with Convergent Therapeutics CEO Dr. Phil Kantoff
The Coming Wave Of Radio(bio)pharmaceuticals
Radiopharmaceutical Technology Creates Novel Radioantibodies to Treat Prostate Cancer with Dr. Phil Kantoff and Alex Brown — Convergent Therapeutics
AACR: Philip Kantoff Discusses Convergent’s Unique Path to Treating Prostate Cancer
Dr. Philip Kantoff — Radiopharmaceutical cancer targeting with Convergent Therapeutics